ADENOCARCINOM CANCER
/ AIDS LYMPHOMA CANCER / BRAIN CANCER TUMOR / BREAST
CANCER
SINUS SARCOMA CANCER /
INFLAMMATORY
BREAST CANCER (IBC) TUMOR / PROSTATE CANCER TUMOR / TONSIL CANCER TUMOR
NECK CANCER TUMOR I / NECK CANCER TUMOR II / BREAST
CANCER, HEAD and NECK TUMOR, DEEP TUMORS
Neck Tumor
Neck cancer treatment
One patient's result. These pictures were taken before and after the Hyperthermia
treatment, combined with low radiation dose, on a neck cancer patient.
Before treatment, 07/08/05
After treatment, 07/15/05
After treatment,
07/15/05
After treatment, 07/15/05
After treatment, 08/02/05
After four weeks of reatment, 08/09/05
After four weeks of reatment,
08/09/05
After four weeks of reatment, 08/09/05
After 5
weeks of treatment, 08/15/05
After 5 weeks of treatment, 08/15/05
After 5 weeks of treatment, 08/15/05
After 5 weeks of treatment, 08/15/05
After treatment, 08/30/05
After treatment, 08/30/05
After treatment, 08/30/05
To request an information
package, please fill out the Information Request
Form
You are visitor No.:
Top of Page /
Home / Treatment
Results
Scientific paper presented by Dr. James I. Bicher, in the 2002 International Clinical
Hyperthermia Society Meeting, Florida, USA.
REPORT: TWO CASES OF STAGE III CANCER OF
THE TONSILS WITH IMMUNE STIMULATION
AND THERMORADIOTHERAPY
W. Douglas Brodie, M.D., H.D.M. and James I. Bicher, M.D.
Brodie’s Clinic, Reno, Nevada, USA
and Valley Cancer Institute, Los Angeles, California, USA
Two patients with advanced squamous cell carcinoma of the tongue with extensive cancer
neck metastasis and intractable pain were treated in the past 18 months with a combination
Immune Stimulation and Thermoradiotherapy. The rationale for IS is based upon the
observation that neck cancer is so often associated with a depressed or depleted immune
system. Consequently the use of immune activating substances is emphasized. Intravenous
infusions containing selenium, germanium, magnesium, vitamin C, B complex, folic acid,
zinc, and glutahione are given daily, 5 days per week for three weeks. Each infusion is
followed by an intramuscular injection of a poly peptide mixture derived from thymus and
spleen. These peptides are activators of T-cells and other cellular elements of the immune
system. In adition to the injectables a number of special oral supplements are given both
during and after the initial infusions. These include vitamin A in emulsified form,
vitamin E, pancreatic enzymes, thymus extract, inositol hexaphosphate Co enzyme Q10, and
Transfer factor. These are continued on an out patients basis.
Thermoradiotherapy was administered as previously described with protracted
hyperfractionation to a total of 7000 cGy combined with daily hyperthermia treatments to
the area of primary tumor and both necks. Thermoradiotherapy was instituted at the end of
the induction phase of the IS treatment.
The results were gratifying, with complete responses accomplished in both cases, as
documented clinically, radiographically and normal tumor markers. Pain paliation was
remarkable and early. There have been no recurrence or dissemination at this point.
